News

How long does post-COVID-19 condition (PCC) last? And who remains most vulnerable? In our new study from the EuCARE POSTCOVID project, we followed over 850 patients — both hospitalized and not — up to 2 years after SARS-CoV-2 infection. Our findings shed light on the evolving burden and clinical presentation of PCC. Key findings:• How […]

The EuCARE Annual Meeting brought together our partners from across Europe (and beyond!) in the stunning Certosa di Pontignano, Siena 🇮🇹, a place where history and science truly meet. Over two days, teams shared results, insights, and new ideas as we move into the final phase of the project. From virology to epidemiology, data science

The Organising Bureau of European School Student Unions, a EuCARE partner, shared with the EuCARE during our Annual meeting, an easy to understand summary of some results from the WP4- Schools Cohort! When schools went online, the impact went far beyond the screen. 💻 The EuCARE project followed students in Italy, Portugal, and Mexico to

We’re gathering in Siena (and online) for the EuCARE 2025 Annual Meeting! Two days dedicated to consolidating results and planning for impact — bringing together all partners to discuss ongoing research, share findings, and shape the final year of our Horizon Europe project. This meeting will also count with the participation of external experts from

We are proud to share that Sara Gandini, EuCARE partner and researcher at the European Institute of Oncology (IEO), has been included once again in the Stanford/Elsevier Top 2% Scientists List 2025, recognising the world’s most influential scientists based on standardised citation metrics and research impact. Sara also ranks 27th among Italian women scientists in

Today marks the beginning of the fifth and final year of the EuCARE project  Since its launch, EuCARE has connected researchers, clinicians, and institutions across the globe to better understand and respond to infectious diseases.As we enter this last year, our focus remains clear:🔬 advancing knowledge,🤝 strengthening collaboration, and💡 ensuring science continues to make a difference for

On September 26th, EuCARE and VIROMARKERS joined the European Researchers’ Night 2025 in Frascati 🇮🇹, part of NET – scieNcE Together 2024–2025. This annual event transforms Europe into a huge scientific laboratory, connecting researchers and citizens through interactive activities, science villages, and open labs across over 30 Italian cities. With Maria Skłodowska Curie as the

We are proud to share that our study, “Risk of Long COVID Symptoms and Conditions After SARS-CoV-2 Compared to Other Respiratory Viral Infections: A Systematic Review and Meta-Analysis”, was presented as a poster at the Nordic HIV & Virology Conference 2025. The research highlights:✅ Higher risk of long-term symptoms such as pulmonary embolism, fatigue, abnormal

A EuCARE survey with 2,079 HCWs across 🇵🇹 🇧🇷 🇩🇪 🇵🇱 🇱🇹 — led by Prof. Francis Drobniewski (Imperial College London) — revealed: What helped? Easy workplace access, clear scientific info, and seeing peers get vaccinated. 👉 One lesson: vaccine promotion must be tailored — not one-size-fits-all. Read the full manuscript here!

On August 25, EuCARE partners gathered prestigious seat of the Faculty of Medicine of UFMG, Belo Horizonte, for a dedicated Post Acute Infection Syndrome (PAIS) meeting. Julia Caporali (UFMG), Dario Corsini (EuResist), Francesca Incardona (EuResist), Jorge Pinto (UFMG) and Flavia Faleiro (UFMG) talked about the ongoing studies and perspectives.🔹 PAIS is attracting interest after the